Salute e Benessere
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S
COPENHAGEN, Denmark, April 16, 2024 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results:
Minutes and voting results from the Annual General Meeting will be published on the Company's website within two weeks.
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit
www.bavarian-nordic.com .
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors,
graham@paddockcircle.com , Tel: +1 781 686 9600
Company Announcement no. 07 / 2024
Attachment
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti